Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem

European Journal of Clinical Pharmacology

Volumn 54, Issue 2, 1998, Pages 163-166

  Luurila, H ^a   Kivisto K T ^a   Neuvonen, P J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Itraconazole; Zolpidem

Indexed keywords

HYPNOTIC AGENT; ITRACONAZOLE; PLACEBO; ZOLPIDEM TARTRATE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL;

ADULT; ANTIFUNGAL AGENTS; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; ITRACONAZOLE; MALE; PYRIDINES; REFERENCE VALUES;

EID: 0031954051     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050439     Document Type: Article

References (16)

1. Olkkola KT, Backman JT, Neuvonen PJ (1994) Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther 55: 481-485
2. Varhe A, Olkkola KT, Neuvonen PJ (1994) Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther 56: 601 607
3. Pichard L, Gillet G, Bonfils C, Domergue J, Thénot JP, Maurel P (1995) Oxidative metabolism of zolpidem by human liver cytochrome P450s. Drug Metab Dispos 23: 1253-1262
4. Salva P, Costa J (1995) Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 29: 142-153
5. Langtry H, Benfield P (1990) Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40: 291-313
6. Stanke F, Jourdil N, Bessard J, Bessard G (1996) Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection. J Chromatogr B Biomed Appl 675: 43-51
7. Remmel RP, Dombrovskis D, Canafax DM (1988) Assay of itraconazole in leukemic patient plasma by reversed-phase small-bore liquid chromatography. J Chromatogr 432: 388-394
8. Allenmark S, Edebo A, Lindgren K (1990) Determination of itraconazole in serum with high-performance liquid chromatography and fluorescence detection. J Chromatogr 532: 203-206
9. Neuvonen PJ, Varhe A, Olkkola KT (1996) The effect of ingestion time interval on the interaction between itraconazole and triazolam. Clin Pharmacol Ther 60: 326-331
10. Fraisse J, Garrigou-Gadenne D, Thénot JP (1996) Pharmacokinetic and metabolic profiles of zolpidem. In: Freeman H, Puech AJ, Roth T (eds) Zolpidem: an update of its pharmacological properties and therapeutic place in the management of insomnia. Elsevier, Paris, pp 45-57
11. Back DJ, Tjia JF (1991) Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol 32: 624-626
12. Villikka K, Kivistö KT, Luurila H, Neuvonen PJ (1997) Rifampin reduces plasma concentrations and effects of zolpidem. Clin Pharmacol Ther 62: 629-634
13. Kivistö KT, Lamberg TS, Kantola T, Neuvonen PJ (1997) Plasma huspirone concentrations are greatly increased by erythromycin and itraconazole. Clin Pharmacol Ther 62: 348-354
14. Jalava K-M, Olkkola KT, Neuvonen PJ (1996) Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone. Eur J Clin Pharmacol 51: 331-334
15. Ahonen J, Olkkola KT, Neuvonen PJ (1996) The effect of the antimycotic itraconazole on the pharmacokinetics and pharmacodynamics of diazepam. Fundam Clin Pharmacol 10: 314-318
16. Ahonen J, Olkkola KT, Neuvonen PJ (1996) Lack of effect of antimycotic itraconazole on the pharmacokinetics or pharmacodynamics of temazepam. Ther Drug Monit 18: 124-127